Article
SMAD2 promotes myogenin expression and terminal myogenic differentiation
18 Jan 2021
Abstract excerpt
ABSTRACT SMAD2 is a transcription factor, the activity of which is regulated by members of the transforming growth factor β (TGFβ) superfamily. Although activation of SMAD2 and SMAD3 downstream of TGFβ or myostatin signaling is known to inhibit myogenesis, we found that SMAD2 in the absence of TGFβ signaling promotes terminal myogenic differentiation. We found that, during myogenic differentiation, SMAD2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
